Skip to main content

Table 1 CPA and Non-CPA patient characteristics

From: Prospective study of the serum Aspergillus-specific IgG, IgA and IgM assays for chronic pulmonary aspergillosis diagnosis

Characteristic

CPA patients (n = 42)

Non-CPA patients (n = 60)

Male gender

20 (47.6%)

37 (61.7%)

Age (years) (mean ± SD)

54.6 ± 16.8

52.7 ± 18.1

Underlying lung diseases

 Bronchiectasis

12 (28.6%)

18 (30.0%)

 COPD

8 (19.0%)

10 (16.7%)

 Emphysema

6 (14.3%)

1 (1.7%)

 Previous tuberculosis

3 (7.1%)

4 (6.7%)

 Interstitial pneumonia

2 (4.8%)

2 (3.3%)

 Asthma

2 (4.8%)

8 (13.3%)

 Pulmonary embolism

2 (4.8%)

0

 Prior pneumonia

2 (4.8%)

5 (8.3%)

 Chronic bronchitis

2 (4.8%)

8 (13.3%)

 Pulmonary sarcoidosis

1 (2.4%)

2 (3.3%)

 Eosinophilic pneumonia

1 (2.4%)

0

 No underlying pulmonary diseases

4 (9.5%)

5 (8.3%)

Underlying systemic diseases

 Diabetes mellitus

6 (14.3%)

9 (15.0%)

 Heart failure

5 (11.9%)

8 (13.3%)

 Rheumatic disease

5 (11.9%)

3 (5.0%)

 Chronic renal failure

3 (7.1%)

4 (6.7%)

Chronic pulmonary or systemic symptoms

 Cough

32 (76.2%)

45 (75.0%)

 Sputum

30 (71.4%)

38 (63.3%)

 Fever

19 (45.2%)

34 (56.7%)

 Dyspnea

17 (40.5%)

30 (50.0%)

 Hemoptysis

11 (26.2%)

9 (15.0%)

 Chest pain

2 (4.8%)

2 (3.3%)

Chest CT findings

 Bronchiectasis

12 (28.6%)

18 (30.0%)

 Consolidation

8 (19.0%)

9 (15.0%)

 Cavitation

5 (11.9%)

5 (8.3%)

 Pleural effusion

4 (9.5%)

8 (13.3%)

 Nodules

4 (9.5%)

19 (31.7%)

 Bullae of lung

3 (7.1%)

1 (1.7%)

 Fibrotic changes

3 (7.1%)

5 (8.3%)

 Pleural thickening

3 (7.1%)

3 (5.0%)

 Fungal ball

2 (4.8%)

0

 Mass

2 (4.8%)

6 (10.0%)

 Halo sign

2 (4.8%)

0

 Air crescent sign

1 (2.4%)

0

  1. COPD chronic obstructive pulmonary disease, CPA chronic pulmonary aspergillosis, CT computed tomography